Insider · CIK 0001741533
John F. Paolini
officer
Files at KNSA (Kiniksa Pharmaceuticals International, plc). First filing May 9, 2025, latest Mar 4, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $5.8M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KNSA: Kiniksa Pharmaceuticals International, plc
KNSAOct 9, 2026 · close 79.78
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 23Weak | Kiniksa Pharmaceuticals International, plc | $1.8M 40,000 shares | -39% | +147% from low-4% from high | |
| 40Moderate | Kiniksa Pharmaceuticals International, plc | $3.1M 82,542 shares | -57% | +104% from low-9% from high | |
| 29Weak | Kiniksa Pharmaceuticals International, plc | $955k 29,325 shares | -34% | +80% from low-1% from high | |
| 0Weak | Kiniksa Pharmaceuticals International, plc | $5,400 200 shares | -0% | +47% from low-4% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +2,497 | - | - | 68,120 | 39 d ago |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +1,624 | - | - | 69,744 | 39 d ago |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +1,750 | - | - | 71,494 | 39 d ago |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +2,457 | - | - | 73,951 | 39 d ago |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | FTax withholding Class A Ordinary Share | -4,029 | $79.28 | $319k | 69,922 | 39 d ago |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Restricted Share Unitderivative | +6,700 | $0.00 | $0 | 6,700 | 39 d ago |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Share Optionderivative | +26,750 | $0.00 | $0 | 26,750 | 39 d ago |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitderivative | -2,457 | $0.00 | $0 | 7,371 | 39 d ago |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitderivative | -1,750 | $0.00 | $0 | 3,500 | 39 d ago |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitderivative | -1,624 | $0.00 | $0 | 1,624 | 39 d ago |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitderivative | -2,497 | $0.00 | $0 | 0 | 39 d ago |
| Mar 2, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +40,000 | $10.36 | $414k | 101,324 | Mar 4, 2026 |
| Mar 2, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -12,063 | $44.20 | $533k | 89,261 | Mar 4, 2026 |
| Mar 2, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -22,223 | $44.88 | $997k | 67,038 | Mar 4, 2026 |
| Mar 2, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -5,714 | $45.92 | $262k | 61,324 | Mar 4, 2026 |
| Mar 2, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -40,000 | $0.00 | $0 | 58,424 | Mar 4, 2026 |
| Oct 31, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +36,542 | $3.80 | $139k | 97,866 | Nov 4, 2025 |
| Oct 31, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +46,000 | $8.83 | $406k | 143,866 | Nov 4, 2025 |
| Oct 31, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -82,542 | $37.14 | $3.1M | 61,324 | Nov 4, 2025 |
| Oct 31, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -36,542 | $0.00 | $0 | 0 | Nov 4, 2025 |
| Oct 31, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -46,000 | $0.00 | $0 | 0 | Nov 4, 2025 |
| Sep 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +1,750 | - | - | 59,153 | Sep 3, 2025 |
| Sep 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +1,624 | - | - | 60,777 | Sep 3, 2025 |
| Sep 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +2,498 | - | - | 63,275 | Sep 3, 2025 |
| Sep 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | FTax withholding Class A Ordinary Share | -2,841 | $33.49 | $95k | 60,434 | Sep 3, 2025 |
| Sep 2, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +1,725 | - | - | 62,159 | Sep 3, 2025 |
| Sep 2, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | FTax withholding Class A Ordinary Share | -835 | $34.28 | $29k | 61,324 | Sep 3, 2025 |
| Sep 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Restricted Share Unitderivative | +9,828 | $0.00 | $0 | 9,828 | Sep 3, 2025 |
| Sep 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Share Optionderivative | +39,364 | $0.00 | $0 | 39,364 | Sep 3, 2025 |
| Sep 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitderivative | -1,750 | $0.00 | $0 | 5,250 | Sep 3, 2025 |
| Sep 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitderivative | -1,624 | $0.00 | $0 | 3,248 | Sep 3, 2025 |
| Sep 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitderivative | -2,498 | $0.00 | $0 | 2,497 | Sep 3, 2025 |
| Sep 2, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitderivative | -1,725 | $0.00 | $0 | 0 | Sep 3, 2025 |
| Aug 6, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +29,325 | $3.80 | $111k | 86,728 | Aug 8, 2025 |
| Aug 6, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -29,325 | $32.55 | $955k | 57,403 | Aug 8, 2025 |
| Aug 6, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -29,325 | $0.00 | $0 | 36,542 | Aug 8, 2025 |
| May 7, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +200 | $3.80 | $760 | 57,603 | May 9, 2025 |
| May 7, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -200 | $27.00 | $5,400 | 57,403 | May 9, 2025 |
| May 7, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -200 | $0.00 | $0 | 65,867 | May 9, 2025 |
| May 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Performance Share Unitderivative | +4,954 | $0.00 | $0 | 4,954 | May 5, 2025 |
| May 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Performance Share Unitderivative | +5,201 | $0.00 | $0 | 5,201 | May 5, 2025 |
| May 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Performance Share Optionderivative | +8,007 | $0.00 | $0 | 8,007 | May 5, 2025 |
| May 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Performance Share Optionderivative | +8,266 | $0.00 | $0 | 8,266 | May 5, 2025 |
| Apr 7, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +2,498 | - | - | 58,137 | Apr 9, 2025 |
| Apr 7, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | FTax withholding Class A Ordinary Share | -734 | $20.28 | $15k | 57,403 | Apr 9, 2025 |
| Apr 7, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitderivative | -2,498 | $0.00 | $0 | 2,497 | Apr 9, 2025 |
| Apr 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +1,624 | - | - | 54,880 | Apr 3, 2025 |
| Apr 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +1,750 | - | - | 56,630 | Apr 3, 2025 |
| Apr 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | FTax withholding Class A Ordinary Share | -477 | $21.77 | $10k | 56,153 | Apr 3, 2025 |
| Apr 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | FTax withholding Class A Ordinary Share | -514 | $21.77 | $11k | 55,639 | Apr 3, 2025 |
| Apr 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Share Optionderivative | +39,364 | $0.00 | $0 | 39,364 | Apr 3, 2025 |
| Apr 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Restricted Share Unitderivative | +9,828 | $0.00 | $0 | 9,828 | Apr 3, 2025 |
| Apr 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Performance Share Unitderivative | +19,657 | $0.00 | $0 | 19,657 | Apr 3, 2025 |
| Apr 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitderivative | -1,624 | $0.00 | $0 | 3,248 | Apr 3, 2025 |
| Apr 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitderivative | -1,750 | $0.00 | $0 | 5,250 | Apr 3, 2025 |
| Mar 16, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +1,725 | - | - | 53,763 | Mar 19, 2025 |
| Mar 16, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | FTax withholding Class A Ordinary Share | -507 | $22.61 | $11k | 53,256 | Mar 19, 2025 |
| Mar 16, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitderivative | -1,725 | $0.00 | $0 | 0 | Mar 19, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.